MiNK Therapeutics, Inc.
US ˙ NasdaqCM ˙ US6036931029

SecurityINKT / MiNK Therapeutics, Inc.
InsiderUlf Wiinberg
This page shows the track record and history of WIINBERG ULF insider trades in MiNK Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Ulf Wiinberg in INKT / MiNK Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-07-19 16,661 1.3930 1,666 13.9300 23,209 27 3.4000 -17,544 -75.59
2022-07-18 3,339 1.3290 334 13.2900 4,438

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INKT / MiNK Therapeutics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Ulf Wiinberg in INKT / MiNK Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

INKT / MiNK Therapeutics, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-03 2025-09-02 4 WIINBERG ULF INKT Common Stock A - Award D 13.8600 1,011 14 18,971
2025-06-04 2025-06-02 4 WIINBERG ULF INKT Common Stock A - Award D 7.1700 1,953 14 17,960
2025-03-05 2025-03-03 4 WIINBERG ULF INKT Common Stock A - Award D 8.7900 1,593 14 16,007
2024-12-03 2024-12-01 4 WIINBERG ULF INKT Common Stock A - Award D 0.7300 20,476 15 144,181
2024-09-05 2024-09-03 4 WIINBERG ULF INKT Common Stock A - Award D 0.8200 18,295 15 123,705
2024-06-05 2024-06-03 4 WIINBERG ULF INKT Common Stock A - Award D 0.9900 15,077 15 105,410
2024-03-05 2024-03-01 4 WIINBERG ULF INKT Common Stock A - Award D 0.9500 15,790 15 90,333
2023-12-05 2023-12-01 4 WIINBERG ULF INKT Common Stock A - Award D 1.0400 14,424 15 74,543
2023-09-06 2023-09-01 4 WIINBERG ULF INKT Common Stock A - Award D 1.4600 9,590 14 60,119
2023-06-02 2023-06-01 4 WIINBERG ULF INKT Common Stock A - Award D 1.7600 7,955 14 50,706
2023-03-03 2023-03-01 4 WIINBERG ULF INKT Common Stock A - Award D 2.0900 6,699 14 42,751
2022-12-05 2022-12-01 4 WIINBERG ULF INKT Common Stock A - Award D 2.6100 5,364 14 36,052
2022-09-19 2022-09-15 4 WIINBERG ULF INKT Common Stock A - Award D 2.6200 10,688 28 10,688
2022-07-21 2022-07-19 4 WIINBERG ULF INKT Common Stock P - Purchase D 1.3930 16,661 23 298,300
2022-07-21 2022-07-18 4 WIINBERG ULF INKT Common Stock P - Purchase D 1.3290 3,339 4 281,639
2022-03-11 2022-03-09 4 WIINBERG ULF INKT Stock Option (Right to Buy) A - Award D 2.89 15,000 15,000
2021-10-20 3 WIINBERG ULF INKT Common Stock D 278,300
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)